Literature DB >> 15987244

FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling.

Lars P van der Heide1, Frank M J Jacobs, J Peter H Burbach, Marco F M Hoekman, Marten P Smidt.   

Abstract

Forkhead members of the 'O' class (FoxO) are transcription factors crucial for the regulation of metabolism, cell cycle, cell death and cell survival. FoxO factors are regulated by insulin-mediated activation of PI3K (phosphoinositide 3-kinase)-PKB (protein kinase B) signalling. Activation of PI3K-PKB signalling results in the phosphorylation of FoxO factors on three conserved phosphorylation motifs, which are essential for the translocation of FoxO factors from the nucleus to the cytosol. FoxO6, however, remains mostly nuclear due to the fact that its shuttling ability is dramatically impaired. FoxO1, FoxO3 and FoxO4 all contain an N- and C-terminal PKB motif and a motif located in the forkhead domain. FoxO6 lacks the conserved C-terminal PKB motif, which is the cause of the shuttling impairment. Since FoxO6 can be considered constitutively nuclear, we investigated whether it is also a constitutively active transcription factor. Our results show that FoxO6 transcriptional activity is inhibited by growth factors, independent of shuttling, indicating that it is not constitutively active. The PKB site in the forkhead domain (Ser184) regulated the DNA binding characteristics and the N-terminal PKB site acted as a growth factor sensor. In summary, FoxO6 is not a constitutively active transcription factor and can be regulated by growth factors in a Thr26- and Ser184-dependent manner, independent of shuttling to the cytosol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987244      PMCID: PMC1276963          DOI: 10.1042/BJ20050525

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR.

Authors:  J Nakae; V Barr; D Accili
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

3.  Regulation of FoxO activity by CBP/p300-mediated acetylation.

Authors:  Lars P van der Heide; Marten P Smidt
Journal:  Trends Biochem Sci       Date:  2005-02       Impact factor: 13.807

4.  Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.

Authors:  G Rena; A R Prescott; S Guo; P Cohen; T G Unterman
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

5.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

6.  Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.

Authors:  G Rena; S Guo; S C Cichy; T G Unterman; P Cohen
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

7.  Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.

Authors:  S Guo; G Rena; S Cichy; X He; P Cohen; T Unterman
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

8.  Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.

Authors:  D Schmoll; K S Walker; D R Alessi; R Grempler; A Burchell; S Guo; R Walther; T G Unterman
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

9.  Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways.

Authors:  C M Cahill; G Tzivion; N Nasrin; S Ogg; J Dore; G Ruvkun; M Alexander-Bridges
Journal:  J Biol Chem       Date:  2000-12-20       Impact factor: 5.157

10.  Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence.

Authors:  J E Ayala; R S Streeper; J S Desgrosellier; S K Durham; A Suwanichkul; C A Svitek; J K Goldman; F G Barr; D R Powell; R M O'Brien
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

View more
  45 in total

Review 1.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  A FOXO-Pak1 transcriptional pathway controls neuronal polarity.

Authors:  Luis de la Torre-Ubieta; Brice Gaudillière; Yue Yang; Yoshiho Ikeuchi; Tomoko Yamada; Sara DiBacco; Judith Stegmüller; Ulrich Schüller; Dervis A Salih; David Rowitch; Anne Brunet; Azad Bonni
Journal:  Genes Dev       Date:  2010-04-15       Impact factor: 11.361

3.  FoxO1 links hepatic insulin action to endoplasmic reticulum stress.

Authors:  Adama Kamagate; Dae Hyun Kim; Ting Zhang; Sandra Slusher; Roberto Gramignoli; Stephen C Strom; Suzanne Bertera; Steven Ringquist; H Henry Dong
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

4.  FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

Authors:  Ji-Hye Paik; Ramya Kollipara; Gerald Chu; Hongkai Ji; Yonghong Xiao; Zhihu Ding; Lili Miao; Zuzana Tothova; James W Horner; Daniel R Carrasco; Shan Jiang; D Gary Gilliland; Lynda Chin; Wing H Wong; Diego H Castrillon; Ronald A DePinho
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

5.  Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth.

Authors:  George B John; Teresa D Gallardo; Lane J Shirley; Diego H Castrillon
Journal:  Dev Biol       Date:  2008-06-20       Impact factor: 3.582

Review 6.  FoxO6 in glucose metabolism (FoxO6).

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; H Henry Dong
Journal:  J Diabetes       Date:  2013-05-28       Impact factor: 4.006

7.  FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Ann Piccirillo; Yong Fan; Radha Uppala; Eric Goetzman; H Henry Dong
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

Review 8.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16

9.  Distinct activities of the germline and somatic reproductive tissues in the regulation of Caenorhabditis elegans' longevity.

Authors:  Tracy M Yamawaki; Nuno Arantes-Oliveira; Jennifer R Berman; Peichuan Zhang; Cynthia Kenyon
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

Review 10.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.